Evidence map›Paper›PMID 19481041›Full record

ReviewJournal of feline medicine and surgery2009

Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management.

Herman Egberink, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Tadeusz Frymus, Tim Gruffydd-Jones, Katrin Hartmann, Margaret J Hosie, Albert Lloret, Hans Lutz and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of feline medicine and surgery, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Outbreak management of multidrug-resistantJournal of feline medicine and surgery · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. AreViruses · 2021
    Article
  13. Biosecurity in pig farms: a review.Porcine health management · 2021
    Review
  14. Article
  15. Prevalence of feline herpesvirus-1, feline calicivirus,Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2020
    Article
  16. Bacterial Pneumonia in Dogs and Cats: An Update.The Veterinary clinics of North America. Small animal practice · 2020
    Review
  17. Characterization of a UniqueInternational journal of molecular sciences · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Herman EgberinkEuropean Advisory Board on Cat Diseases (ABCD). H.F.Egberink@uu.nl
Diane Addie
Sándor Belák
Corine Boucraut-Baralon
Tadeusz Frymus
Tim Gruffydd-Jones
Katrin Hartmann
Margaret J Hosie
Albert Lloret
Hans Lutz
Fulvio Marsilio
Maria Grazia Pennisi
Alan D Radford
Etienne Thiry
Uwe Truyen
Marian C Horzinek
University of Liège · BE

Funding

Biotechnology and Biological Sciences Research Council BB/D008425/1Medical Research Council G0300387
6 · The paper itself

Abstract

overviewBordetella bronchiseptica is a Gram-negative bacterium that colonises the respiratory tract of mammals and is considered to be a primary pathogen of domestic cats. It is sensible to consider B bronchiseptica as a rare cause of zoonotic infections. The bacterium is susceptible to common disinfectants. INFECTION: The bacterium is shed in oral and nasal secretions of infected cats. Dogs with respiratory disease are an infection risk for cats. The microorganism colonises the ciliated epithelium of the respiratory tract of the host, establishing chronic infections. DISEASE SIGNS: A wide range of respiratory signs has been associated with B bronchiseptica infection, from a mild illness with fever, coughing, sneezing, ocular discharge and lymphadenopathy to severe pneumonia with dyspnoea, cyanosis and death. DIAGNOSIS: Bacterial culture and PCR lack sensitivity. Samples for isolation can be obtained from the oropharynx (swabs) or via transtracheal wash/ bronchoalveolar lavage. DISEASE MANAGEMENT: Antibacterial therapy is indicated, even if the signs are mild. Where sensitivity data are unavailable, tetracyclines are recommended. Doxycycline is the antimicrobial of choice. Cats with severe B bronchiseptica infection require supportive therapy and intensive nursing care. VACCINATION RECOMMENDATIONS: In some European countries an intranasal modified-live virus vaccine is available. The modified-live product is licensed for use as a single vaccination with annual boosters. Cats should not be routinely vaccinated against B bronchiseptica (non-core), since the infection generally causes only a mild disease.

Indexed as

Practice Guidelines as TopicAnimalsAnti-Bacterial AgentsBacterial VaccinesBordetella bronchisepticaBordetella InfectionsCat DiseasesCatsRespiratory Tract InfectionsSocietiesUnited StatesVaccinationVeterinary MedicineAnti-Bacterial AgentsBacterial Vaccines

Identifiers

PMID19481041
PMCPMC11132281
OpenAlexW1984156324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.